» Authors » Juan Antonio Vargas Nunez

Juan Antonio Vargas Nunez

Explore the profile of Juan Antonio Vargas Nunez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 131
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Oblitas C, Demelo-Rodriguez P, Alvarez-Sala-Walther L, Rubio-Rivas M, Navarro-Romero F, Giner Galvan V, et al.
Viruses . 2024 Mar; 16(3). PMID: 38543700
Background: This study aimed to validate the role of the D-dimer to lymphocyte ratio (DLR) for mortality prediction in a large national cohort of hospitalized coronavirus disease 2019 (COVID-19) patients....
2.
Mingote A, Marrero Garcia R, Santos Gonzalez M, Castejon R, Salas Anton C, Vargas Nunez J, et al.
Crit Care . 2022 Oct; 26(1):316. PMID: 36258235
Background: Mechanical ventilation increases the risk of lung injury (VILI). Some authors propose that the way to reduce VILI is to find the threshold of driving pressure below which VILI...
3.
Rubio-Rivas M, Mora-Lujan J, Formiga F, Arevalo-Canas C, Lebron Ramos J, Villalba Garcia M, et al.
J Gen Intern Med . 2022 Apr; 37(8):1980-1987. PMID: 35396659
Background: The WHO ordinal severity scale has been used to predict mortality and guide trials in COVID-19. However, it has its limitations. Objective: The present study aims to compare three...
4.
Garcia-Cervera C, Giner-Galvan V, Wikman-Jorgensen P, Laureiro J, Rubio-Rivas M, Gurjian Arena A, et al.
J Gen Intern Med . 2021 Jul; 36(11):3478-3486. PMID: 34287774
Background: Venous thrombotic events (VTE) are frequent in COVID-19, and elevated plasma D-dimer (pDd) and dyspnea are common in both entities. Objective: To determine the admission pDd cut-off value associated...
5.
Martinez Urbistondo M, Mora Vargas A, Exposito Palomo E, Aparicio de Miguel M, Castejon Diaz R, Daimiel L, et al.
Nutr Hosp . 2021 Jun; 38(5):1068-1074. PMID: 34176273
Introduction: coronavirus disease 2019 (COVID-19) encompasses a wide spectrum of symptoms, including respiratory, gastrointestinal, hematological, and dermatological manifestations. The virus interaction with cells located in the respiratory tract causes the...
6.
Del Mar Ayala Gutierrez M, Rubio-Rivas M, Romero Gomez C, Montero Saez A, Perez de Pedro I, Homs N, et al.
J Clin Med . 2021 Apr; 10(9). PMID: 33922777
(1) Objectives: To describe the clinical characteristics and clinical course of hospitalized patients with COVID-19 and autoimmune diseases (ADs) compared to the general population. (2) Methods: We used information available...
7.
Torres-Pena J, Perez-Belmonte L, Fuentes-Jimenez F, Lopez Carmona M, Perez-Martinez P, Lopez-Miranda J, et al.
Drugs . 2021 Mar; 81(6):685-695. PMID: 33782908
Background: The impact of statins on COVID-19 outcomes is important given the high prevalence of their use among individuals at risk for severe COVID-19. Our aim is to assess whether...
8.
Josa-Laorden C, Crestelo-Vieitez A, Garcia Andreu M, Rubio-Rivas M, Sanchez M, Toledo Samaniego N, et al.
J Clin Med . 2021 Mar; 10(5). PMID: 33668766
There is some evidence that male gender could have a negative impact on the prognosis and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of the...
9.
Lora-Tamayo J, Maestro G, Lalueza A, Rubio-Rivas M, Villarreal Paul G, Fernandez F, et al.
J Infect . 2021 Feb; 82(6):276-316. PMID: 33582204
No abstract available.
10.
Mateos Gonzalez M, Sierra Gonzalo E, Casado Lopez I, Fernandez F, Beato Perez J, Monge Monge D, et al.
J Clin Med . 2021 Jan; 10(2). PMID: 33467585
Objectives: A decrease in blood cell counts, especially lymphocytes and eosinophils, has been described in patients with serious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), but there is no knowledge...